Finance

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Earnings call transcript: CAR Group rises on upbeat H2 2026 outlook

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Shein finds there’s no place like China after Vietnam warehouse experiment disappoints  

Govt taps inputs from public sector banks to lure foreign capital

Imricor 1H 2026 slides: FDA clearances advance despite tiny revenue

FPIs turn buyers in IT stocks for first time in 2026, invest Rs 3,358 crore in July

Westpac Q3 2026 slides: steady profit growth as margin pressure looms

Westpac Q3 2026 slides: steady growth masks looming margin pressure